USFDA Archives - Express Pharma

Alembic Pharma gains USFDA final approval for Ivabradine Tablets, 5 mg and 7.5 mg

Cipla’s manufacturing facility in Goa gets VAI classification

Biocon Biologics’ Bengaluru unit gets VAI classification by US FDA

Zydus gains final USFDA approval for Fludrocortisone Acetate Tablets USP, 0.1 mg

Accord BioPharma’s Biosimilar IMULDOSA gains USFDA approval for treatment of chronic inflammatory conditions

Zydus gains final USFDA approval for Paliperidone Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg

Indoco Remedies receives U.S. FDA approval for generic Cetirizine tablets

Alembic gains USFDA final approval for Lamotrigine Extended-Release Tablets USP, 200 mg, 250 mg, and 300 mg

Gilead Sciences signs licencing agreements with six companies to manufacture, commercialise Lenacapavir

Alembic gains EIR for its Oral Solid Formulation Facility(F-1) at Panelav